Dr Svetlana Cherlin
Dr Theophile Bigirumurame
Dr Michael Grayling
Dr Jérémie Nsengimana
Luke Ouma
et al. | Utilising high-dimensional data in randomised clinical trials: a review of methods and practice | 2024 |
|
Professor James Wason
Dr Faye Williamson
| Medicines and Healthcare products Regulatory Agency’s “Consultation on proposals for legislative changes for clinical trials”: a response from the Trials Methodology Research Partnership Adaptive Designs Working Group, with a focus on data sharing | 2023 |
|
Dr Faye Williamson
Dr Cameron Williams
Dr Clare Lendrem
Professor Kevin Wilson
| Sample size determination for point-of-care COVID-19 diagnostic tests: A Bayesian approach | 2023 |
|
Professor Kevin Wilson
Dr Faye Williamson
Dr Joy Allen
Cameron Williams
Dr Tom Hellyer
et al. | Bayesian sample size determination for diagnostic accuracy studies | 2022 |
|
Dr Faye Williamson
| Generalisations of a Bayesian decision-theoretic randomisation procedure and the impact of delayed responses | 2022 |
|
Dr Faye Williamson
Dr Michael Grayling
Professor James Wason
| Subgroup analyses in randomized controlled trials frequently categorized continuous subgroup information | 2022 |
|
Professor James Wason
Dr Faye Williamson
| Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19 | 2020 |
|
Dr Faye Williamson
| A response-adaptive randomization procedure for multi-armed clinical trials with normally distributed outcomes | 2019 |
|
Dr Faye Williamson
| A Bayesian adaptive design for clinical trials in rare diseases | 2017 |
|
